|
|
News Breaks | | | | November 9, 2012 | | 14:27 EDT |  | OSUR | OraSure decline creates long-term buying opportunity, says Barrington
After OraSure reported weaker than expected Q3 results and provided weaker than expected Q4 guidance, Barrington expects the company to start rapidly penetrating the HCV and HIV markets. The firm maintains a $12.50 target and Outperform rating. | |
|
News For OSUR From The Last 14 Days Check below for free stories on OSUR the last two weeks. |
|
|
| There are no results for OSUR |
|
|
|
|
|
|
